Aileron Therapeutics, Inc. (ALRN)
USD 1.86
(-3.13%)
USD 1.86
(-3.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 119 Thousand | 169 Thousand | 121 Thousand | 163 Thousand | 155 Thousand | 218 Thousand |
| Gross Profit | -119 Thousand | -169 Thousand | -121 Thousand | -163 Thousand | -155 Thousand | -218 Thousand |
| Operating Expenses | 16.27 Million | 27.64 Million | 26.6 Million | 20.49 Million | 29.95 Million | 31.9 Million |
| Selling, General and Administrative Expenses | 11.35 Million | 9.68 Million | 9.59 Million | 9.33 Million | 12.29 Million | 13.45 Million |
| Research and Development Expenses | 3.99 Million | 17.96 Million | 17 Million | 11.16 Million | 17.66 Million | 18.44 Million |
| Other Expenses | 928 Thousand | 318 Thousand | 441 Thousand | -800 Thousand | - | - |
| Cost and Expenses | 16.27 Million | 27.64 Million | 26.6 Million | 20.49 Million | 29.95 Million | 31.9 Million |
| Operating Income | -16.27 Million | -27.64 Million | -26.6 Million | -20.49 Million | -29.95 Million | -31.9 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -318 Thousand | -441 Thousand | 661 Thousand | -587 Thousand | 355 Thousand |
| Earnings before Tax | -15.73 Million | -27.32 Million | -26.2 Million | -21.15 Million | -29.36 Million | -31.54 Million |
| Net Income | -15.73 Million | -27.01 Million | -25.76 Million | -21.81 Million | -28.78 Million | -31.54 Million |
| Earnings Per Share Basic | -3.42 | -5.95 | -5.80 | -12.52 | -23.46 | -42.81 |
| Earnings Per Share Diluted | -3.42 | -5.95 | -5.80 | -12.52 | -23.46 | -42.81 |
| Weighted Average Shares Outstanding | 4.59 Million | 4.53 Million | 4.44 Million | 1.74 Million | 1.22 Million | 736.9 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 4.59 Million | 4.53 Million | 4.44 Million | 1.74 Million | 1.22 Million | 736.9 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -15.61 Million | -27.47 Million | -26.48 Million | -20.33 Million | -29.8 Million | -31.32 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 134 Thousand | - | - |
| Cost of Revenue | 4000.00 | 59 Thousand | 119 Thousand | 52 Thousand | 12 Thousand | 12 Thousand |
| Gross Profit | -4000.00 | -59 Thousand | -119 Thousand | 82 Thousand | -12 Thousand | -12 Thousand |
| Operating Expenses | 9.03 Million | 7.2 Million | 15.22 Million | 7.25 Million | 1.97 Million | 2.08 Million |
| Selling, General and Administrative Expenses | 5.29 Million | 3.74 Million | - | 5.27 Million | 1.95 Million | 1.89 Million |
| Research and Development Expenses | 3.74 Million | 3.46 Million | - | 1.97 Million | 22 Thousand | 187 Thousand |
| Other Expenses | 97 Thousand | 92 Thousand | 928 Thousand | 657 Thousand | 1000.00 | 93 Thousand |
| Cost and Expenses | 9.03 Million | 7.2 Million | 15.34 Million | 7.3 Million | 1.97 Million | 2.08 Million |
| Operating Income | -9.03 Million | -7.2 Million | -15.34 Million | -7.3 Million | -1.98 Million | -1.99 Million |
| Interest Expense | - | - | - | -2.04 Million | - | - |
| Income Tax Expense | - | -59 Thousand | - | 581 Thousand | -149 Thousand | -200 Thousand |
| Earnings before Tax | -8.94 Million | -7.11 Million | -15.73 Million | -7.33 Million | -1.82 Million | -1.78 Million |
| Net Income | -8.94 Million | -7.11 Million | -15.73 Million | -7.33 Million | -1.82 Million | -1.78 Million |
| Earnings Per Share Basic | -0.45 | -0.86 | - | -1.54 | -0.40 | -0.39 |
| Earnings Per Share Diluted | -0.45 | -0.86 | - | -1.54 | -0.40 | -0.39 |
| Weighted Average Shares Outstanding | 19.91 Million | 8.3 Million | 4.59 Million | 4.76 Million | 4.54 Million | 4.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.91 Million | 8.3 Million | 4.59 Million | 4.76 Million | 4.54 Million | 4.54 Million |
| Gross Margin | - | - | - | 0.61 | - | - |
| EBIT Margin | - | - | - | -54.10 | - | - |
| Profit Margin | - | - | - | -54.77 | - | - |
| EBITDA | -9.03 Million | -7.2 Million | - | -7.25 Million | -1.95 Million | -2.15 Million |
| Earnings Before Tax Margin | - | - | - | -54.49 | - | - |
ASIANTNE
IIPR-PA
1217
HDELY
1730
WBBW